1. 2145 Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase open label trial. (September 2015) Authors: Taieb, J.; Borg, C.; Lecomte, T.; Lepere, C.; Chatellier, T.; Smith, D.; Dubreuil, P; Mansfield, C.; Moussy, A.; Hermine, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2349 Phase 1b/2 study results for masitinib plus irinotecan in second-line treatment of esophagogastric adenocarcinoma. (September 2015) Authors: Zaanan, A.; Bennouna, J.; Hiret, S.; Douillard, J.Y.; Bouche, O.; Tougeron, D.; Lecomte, T.; Ezenfis, J.; Lepere, C.; Mansfield, C.; Moussy, A.; Dubreuil, P.; Hermine, O.; Taieb, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. (July 2018) Authors: Adenis, A.; Alessio, A.; Aouakli, A.; Azzedine, A.; Bedjaoui, A.; Bidault, A.; Blanchi, A.; Botton, A.; Cadier-Lagnes, A.; Fatisse, A.; Gagnaire, A.; Gilbert, A.; Gueye, A.; Hollebecque, A.; Lemaire, A.; Mahamat, A.; Marre, A.; Patenotte, A.; Rotenberg, A.; Roussel, A. Journal: European journal of cancer Issue: Volume 98(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗